Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
2007 · New England Journal of Medicine · 4,626 citations
https://doi.org/10.1056/nejmoa072761
K
Kathy Wolski
Cleveland Clinic(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
174
Papers
24.9K
Citations
57
h-index
104
i10-index
Kathy Wolski is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Coronary Interventions and Diagnostics & Lipoproteins and Cardiovascular Health & Bariatric Surgery and Outcomes. The author has an h-index of 57, co-authored 148 publications.
Papers by this author
worksMyosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy
2022 · Journal of the American College of Cardiology · 329 citations
https://doi.org/10.1016/j.jacc.2022.04.048
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
2023 · New England Journal of Medicine · 235 citations
https://doi.org/10.1056/nejmoa2302399
Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal Reduction
2023 · JAMA Cardiology · 142 citations
https://doi.org/10.1001/jamacardio.2023.3342
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)
2024 · JAMA · 69 citations
https://doi.org/10.1001/jama.2024.4504
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat